Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul;8(Suppl 3):S341-S345.
doi: 10.21037/tau.2019.05.02.

Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

Ramy Sedhom  1 , Emmanuel S Antonarakis  1
Affiliations
Editorial

Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

Ramy Sedhom et al. Transl Androl Urol. 2019 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: ES Antonarakis: Consulting/advisory relationship (Janssen, Astellas, Sanofi, Dendreon, Medivation, ESSA, AstraZeneca, Amgen, Clovis, Merck); Research funding: (Janssen, Johnson & Johnson, Sanofi, Dendreon, Genentech, Novartis, Tokai, Bristol-Myers Squibb, AstraZeneca, Celgene, Clovis, Merck); ntellectual property rights/inventor/patent holder (Qiagen). R Sedhom has no conflicts of interest to declare.

Comment on

References

    1. Freedland SJ, Richhariya A, Wang H, et al. Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices. Urology 2012;80:293-8. 10.1016/j.urology.2012.04.007 - DOI - PubMed
    1. Levren G, Sadik M, Gjertsson P, et al. Relation between pain and skeletal metastasis in patients with prostate or breast cancer. Clin Physiol Funct Imaging 2011;31:193-5. 10.1111/j.1475-097X.2010.00999.x - DOI - PubMed
    1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243-9s. 10.1158/1078-0432.CCR-06-0931 - DOI - PubMed
    1. Nørgaard M, Jensen AØ, Jacobsen JB, et al. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol 2010;184:162-7. 10.1016/j.juro.2010.03.034 - DOI - PubMed
    1. Asselah J, Sperlich C. Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: questions of choice. Can Urol Assoc J 2013;7:S11-7. 10.5489/cuaj.274 - DOI - PMC - PubMed